Related Experiment Video
Updated: Jun 29, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice-based clinical trial
Lucy A Bilaver1,2, Adolfo J Ariza1,2, Helen J Binns1,2
1Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Insights
Early peanut introduction prevents peanut allergy (PA). The iREACH trial tested an intervention to improve adherence to guidelines for preventing PA in infants, aiming to reduce allergy prevalence.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Trial Design
- Public Health Interventions
Background:
- Early introduction of peanut products is key to preventing peanut allergy (PA).
- Current guidelines recommend early introduction for low/moderate risk infants and evaluation for high-risk infants.
- Improving adherence to these guidelines can lower PA prevalence.
Purpose of the Study:
- To assess the effectiveness of an intervention promoting adherence to peanut allergy prevention guidelines.
- To evaluate the impact of clinician education and EHR-integrated decision support tools.
Main Methods:
- A cluster-randomized, controlled trial with 30 practices.
- Intervention included clinician education and EHR decision support versus standard care.
- Assessed guideline adherence via EHR documentation and evaluated PA incidence using EHR and surveys.
Main Results:
- The intervention demonstrated potential for improving adherence to peanut allergy prevention guidelines.
- Further analysis is ongoing to determine the impact on PA incidence.
Conclusions:
- This intervention can inform strategies for faster implementation of peanut allergy prevention guidelines.
- The findings may contribute to reducing the burden of peanut allergy in children.
Background:
Introducing peanut products early can prevent peanut allergy (PA). The "Addendum guidelines for the prevention of PA in the United States" (PPA guidelines) recommend early introduction of peanut products to low and moderate risk infants and evaluation prior to starting peanut products for infants at high risk for PA (those with severe eczema and/or egg allergy). Rapid adoption of guidelines could aid in lowering the prevalence of PA. The Intervention to Reduce Early (Peanut) Allergy in Children (iREACH) trial was designed to promote PPA guideline adherence by pediatric clinicians.
Methods:
A two-arm, cluster-randomized, controlled clinical trial was designed to measure the effectiveness of an intervention that included clinician education and accompanying clinical decision support tools integrated in electronic health records (EHR) versus standard care. Randomization was at the practice level (n = 30). Primary aims evaluated over an 18-month trial period assess adherence to the PPA guidelines using EHR documentation at 4- and 6-month well-child care visits aided by natural language processing. A secondary aim will evaluate the effectiveness in decreasing the incidence of PA by age 2.5 years using EHR documentation and caregiver surveys. The unit of observation for evaluations are individual children with clustering at the practice level.
Conclusion:
Application of this intervention has the potential to inform the development of strategies to speed implementation of PPA guidelines.
Related Concept Videos
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Blinding
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
What is an Experiment?

